Arcadia Biosciences (NASDAQ:RKDA) Research Coverage Started at StockNews.com

Investment analysts at StockNews.com began coverage on shares of Arcadia Biosciences (NASDAQ:RKDA) in a report released on Tuesday. The firm set a “sell” rating on the basic materials company’s stock.

A number of other analysts have also weighed in on RKDA. HC Wainwright reduced their price objective on shares of Arcadia Biosciences from $10.00 to $6.00 and set a “buy” rating for the company in a research note on Thursday, May 23rd. Lake Street Capital upgraded shares of Arcadia Biosciences to a “strong-buy” rating in a research note on Tuesday, May 14th.

Arcadia Biosciences Price Performance

NASDAQ RKDA opened at $3.00 on Tuesday. The company’s 50 day simple moving average is $2.77 and its two-hundred day simple moving average is $2.62. The stock has a market capitalization of $4.08 million, a PE ratio of -0.58 and a beta of 0.86. Arcadia Biosciences has a 1 year low of $1.85 and a 1 year high of $5.60.

Arcadia Biosciences (NASDAQ:RKDA) last announced its quarterly earnings results on Thursday, May 9th. The basic materials company reported ($1.78) earnings per share for the quarter, beating the consensus estimate of ($2.52) by $0.74. Arcadia Biosciences had a negative net margin of 129.74% and a negative return on equity of 84.27%. The business had revenue of $1.26 million during the quarter, compared to analysts’ expectations of $1.20 million. During the same quarter in the prior year, the company posted ($3.83) EPS. On average, research analysts anticipate that Arcadia Biosciences will post -2.29 EPS for the current year.

Arcadia Biosciences Company Profile

Arcadia Biosciences, Inc produces and markets plant-based food and beverage products in the United States. The company develops crop improvements primarily in wheat to enhance farm economics by improving the performance of crops in the field, as well as their value as food ingredients. Its food, beverage, and body case products include GoodWheat, Zola coconut water, ProVault topical pain relief, and SoulSpring.